Literature DB >> 7490549

Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes.

R Kooijman1, L E Scholtens, G T Rijkers, B J Zegers.   

Abstract

Insulin-like growth factor-I (IGF-I) has been implicated in playing a regulatory role in T cell development and in T cell function. We demonstrate the presence of type I IGF receptors on human thymocytes using radioligand binding assays and flowcytometric analysis. The relative potencies of IGF-I, IGF-II and insulin for competition with 125I- IGF-I indicate the presence of type I IGF receptors. Scatchard analysis revealed that the average number of receptors per thymocyte is 257 +/- 28 with a Kd of 0.12 +/- 0.01. With multicolour flowcytometry using a type I IGF receptor specific monoclonal antibody (alpha IR3), we show that CD4-CD8- cells express 3-4 times more receptors per cell as compared with CD4+CD8+, CD4+CD8- and CD4-CD8+ cells. IGF-I directly stimulated DNA synthesis of thymocytes and potentiated DNA synthesis in mitogen-activated thymocytes. These results indicate that IGF-I can influence T cell development in humans at the level of the thymus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490549     DOI: 10.1677/joe.0.1470203

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  13 in total

1.  Insulin-like growth factor-1 activates Akt and Jun N-terminal kinases (JNKs) in promoting the survival of T lymphocytes.

Authors:  Patrick T Walsh; Loraine M Smith; Rosemary O'Connor
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 2.  Improving immunity in the elderly: current and future lessons from nonhuman primate models.

Authors:  Christine Meyer; Amelia Kerns; Kristen Haberthur; Ilhem Messaoudi
Journal:  Age (Dordr)       Date:  2011-12-20

Review 3.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 4.  IGF1 receptor and thyroid-associated ophthalmopathy.

Authors:  Michelle Mohyi; Terry J Smith
Journal:  J Mol Endocrinol       Date:  2017-12-22       Impact factor: 5.098

Review 5.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

6.  Igf-I stimulates in vivo thymopoiesis after stem cell transplantation in a child with Omenn syndrome.

Authors:  Nina S Ma; Ami J Shah; Mitchell E Geffner; Neena Kapoor
Journal:  J Clin Immunol       Date:  2009-09-24       Impact factor: 8.317

7.  Role of Bone Marrow Maturity, Insulin-Like Growth Factor 1 Receptor, and Forkhead Box Protein N1 in Thymic Involution and Rejuvenation.

Authors:  M Tasaki; V Villani; A Shimizu; M Sekijima; R Yamada; I M Hanekamp; J S Hanekamp; T A Cormack; S G Moran; A Kawai; D H Sachs; K Yamada
Journal:  Am J Transplant       Date:  2016-06-13       Impact factor: 8.086

8.  Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion.

Authors:  Yu-Waye Chu; Sabrina Schmitz; Baishakhi Choudhury; William Telford; Veena Kapoor; Susan Garfield; David Howe; Ronald E Gress
Journal:  Blood       Date:  2008-07-24       Impact factor: 22.113

9.  Divergent frequencies of IGF-I receptor-expressing blood lymphocytes in monozygotic twin pairs discordant for Graves' disease: evidence for a phenotypic signature ascribable to nongenetic factors.

Authors:  Raymond S Douglas; Thomas H Brix; Catherine J Hwang; Laszlo Hegedüs; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

10.  Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients.

Authors:  Gabriel Morrhaye; Hamid Kermani; Jean-Jacques Legros; Frederic Baron; Yves Beguin; Michel Moutschen; Remi Cheynier; Henri J Martens; Vincent Geenen
Journal:  PLoS One       Date:  2009-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.